Peter B. Alexander
Impact in
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 12
- CAR-T cell therapy research 4
- Cancer Immunotherapy and Biomarkers 3
- HER2/EGFR in Cancer Research 2
- Co-authors
- Xiaofan Wang (2 shared papers)Yun Zhang (2 shared papers)Steven L. McKnight (4 shared papers)Jian Wang (2 shared papers)Ondine Cleaver (1 shared paper)Robert E. Hammer (1 shared paper)Leeju C. Wu (1 shared paper)Xiao‐Fan Wang (6 shared papers)
- Journals
- Nature Communications (3 papers)OncoImmunology (3 papers)Cancer Immunology Immunotherapy (2 papers)Nature (2 papers)Proceedings of the National Academy of Sciences (2 papers)
- Partner nations
- United StatesChinaUnited Kingdom
In The Last Decade
Peter B. Alexander
40 papers receiving 2.6k citations
Peter B. Alexander's Hit Papers
Peers
Comparison fields: 5 of 121
- Cancer Research 425
- Oncology 666
- Immunology 400
- Molecular Biology 1.3k
- Aging 30
Countries citing papers authored by Peter B. Alexander
This map shows the geographic impact of Peter B. Alexander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter B. Alexander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter B. Alexander more than expected).
Fields of papers citing papers by Peter B. Alexander
This network shows the impact of papers produced by Peter B. Alexander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter B. Alexander. The network helps show where Peter B. Alexander may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter B. Alexander, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | TGF-β Family Signaling in the Control of Cell Proliferation and Survival Hit paper breakdown → | 2016 | 498 |
| 2 | 2018 | 320 | |
| 3 | 2009 | 307 | |
| 4 | 1972 | 282 | |
| 5 | 1972 | 244 | |
| 6 | Cancer-cell-derived GABA promotes β-catenin-mediated tumour growth and immunosuppression Hit paper breakdown → | 2022 | 180 |
| 7 | 2007 | 74 | |
| 8 | 2014 | 69 | |
| 9 | 2018 | 59 | |
| 10 | 2011 | 55 | |
| 11 | 2016 | 55 | |
| 12 | 2021 | 46 | |
| 13 | 1977 | 43 | |
| 14 | 2015 | 39 | |
| 15 | 2022 | 37 | |
| 16 | 2020 | 34 | |
| 17 | 2020 | 33 | |
| 18 | 2016 | 30 | |
| 19 | 2001 | 30 | |
| 20 | 2018 | 30 |
About Peter B. Alexander
Peter B. Alexander is a scholar working on Molecular Biology, Oncology, Immunology, Epidemiology and Physiology, having authored 43 papers that have together received 2.7k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (6 papers), Telomeres, Telomerase, and Senescence (5 papers), Immune Cell Function and Interaction (4 papers), CAR-T cell therapy research (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Hepatitis B Virus Studies (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and HER2/EGFR in Cancer Research (2 papers). The work is most often cited by research in Cancer Research (425 citations), Oncology (666 citations), Immunology (400 citations), Molecular Biology (1.3k citations) and Aging (30 citations). Peter B. Alexander has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Xiaofan Wang, Yun Zhang, Steven L. McKnight, Jian Wang, Ondine Cleaver, Robert E. Hammer, Leeju C. Wu, Xiao‐Fan Wang, Qi-Jing Li and Lifeng Yuan. Their work appears in journals such as Nature Communications, OncoImmunology, Cancer Immunology Immunotherapy, Nature and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.